A citation-based method for searching scientific literature

Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
Times Cited: 38







List of co-cited articles
228 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
95
42

Professional perspectives about pharmacogenetic testing and managing ancillary findings.
Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
39
28

Managing incidental findings and research results in genomic research involving biobanks and archived data sets.
Susan M Wolf, Brittney N Crock, Brian Van Ness, Frances Lawrenz, Jeffrey P Kahn, Laura M Beskow, Mildred K Cho, Michael F Christman, Robert C Green, Ralph Hall,[...]. Genet Med 2012
296
26

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Robert C Green, Jonathan S Berg, Wayne W Grody, Sarah S Kalia, Bruce R Korf, Christa L Martin, Amy L McGuire, Robert L Nussbaum, Julianne M O'Daniel, Kelly E Ormond,[...]. Genet Med 2013
26

Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
Susanne B Haga, Julianne M O'Daniel, Genevieve M Tindall, Isaac R Lipkus, Robert Agans. Genet Med 2011
40
23

Exploring concordance and discordance for return of incidental findings from clinical sequencing.
Robert C Green, Jonathan S Berg, Gerard T Berry, Leslie G Biesecker, David P Dimmock, James P Evans, Wayne W Grody, Madhuri R Hegde, Sarah Kalia, Bruce R Korf,[...]. Genet Med 2012
122
21

"I want to know what's in Pandora's Box": comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing.
Anne Townsend, Shelin Adam, Patricia H Birch, Zoe Lohn, Francois Rousseau, Jan M Friedman. Am J Med Genet A 2012
120
21

Consumers' views of pharmacogenetics--A qualitative study.
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
32
25

Patients' and physicians' perspectives on pharmacogenetic testing.
Anja Rogausch, Daniela Prause, Anne Schallenberg, Jürgen Brockmöller, Wolfgang Himmel. Pharmacogenomics 2006
80
21

Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
Emily A Fargher, Charlotte Eddy, William Newman, Faieza Qasim, Karen Tricker, Rachel A Elliott, Katherine Payne. Pharmacogenomics 2007
73
21

Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.
Richard R Fabsitz, Amy McGuire, Richard R Sharp, Mona Puggal, Laura M Beskow, Leslie G Biesecker, Ebony Bookman, Wylie Burke, Esteban Gonzalez Burchard, George Church,[...]. Circ Cardiovasc Genet 2010
280
15

To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.
Gabrielle M Christenhusz, Koenraad Devriendt, Kris Dierickx. Eur J Hum Genet 2013
105
15

Researcher perspectives on disclosure of incidental findings in genetic research.
Meredith C Meacham, Helene Starks, Wylie Burke, Kelly Edwards. J Empir Res Hum Res Ethics 2010
48
15

Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting.
Nancy R Downing, Janet K Williams, Sandra Daack-Hirsch, Martha Driessnack, Christian M Simon. Patient Educ Couns 2013
40
15

Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
155
15

Stakeholder views on pharmacogenomic testing.
Haridarshan N Patel, Iulia D Ursan, Patrick M Zueger, Larisa H Cavallari, A Simon Pickard. Pharmacotherapy 2014
34
17

Feedback of individual genetic results to research participants: in favor of a qualified disclosure policy.
Annelien L Bredenoord, N Charlotte Onland-Moret, Johannes J M Van Delden. Hum Mutat 2011
87
13


Managing incidental findings in human subjects research: analysis and recommendations.
Susan M Wolf, Frances P Lawrenz, Charles A Nelson, Jeffrey P Kahn, Mildred K Cho, Ellen Wright Clayton, Joel G Fletcher, Michael K Georgieff, Dale Hammerschmidt, Kathy Hudson,[...]. J Law Med Ethics 2008
458
13

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting.
Conrad V Fernandez, Caron Strahlendorf, Denise Avard, Bartha M Knoppers, Colleen O'Connell, Eric Bouffet, David Malkin, Nada Jabado, Kym Boycott, Poul H Sorensen. Genet Med 2013
35
14


Informed consent and genomic incidental findings: IRB chair perspectives.
Christian M Simon, Janet K Williams, Laura Shinkunas, Debra Brandt, Sandra Daack-Hirsch, Martha Driessnack. J Empir Res Hum Res Ethics 2011
34
14

Researcher and institutional review board chair perspectives on incidental findings in genomic research.
Janet K Williams, Sandra Daack-Hirsch, Martha Driessnack, Nancy Downing, Laura Shinkunas, Debra Brandt, Christian Simon. Genet Test Mol Biomarkers 2012
26
19

Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results.
Susanne B Haga, Kensaku Kawamoto, Robert Agans, Geoffrey S Ginsburg. Genet Med 2011
14
35

Assessing patient readiness for the clinical adoption of personalized medicine.
A M Issa, W Tufail, J Hutchinson, J Tenorio, M Poonam Baliga. Public Health Genomics 2009
39
13

Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
Jinger G Hoop, Maria I Lapid, Rene M Paulson, Laura Weiss Roberts. J Clin Psychiatry 2010
43
13

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
264
13

Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
41
13

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
113
13


Exome sequencing as a tool for Mendelian disease gene discovery.
Michael J Bamshad, Sarah B Ng, Abigail W Bigham, Holly K Tabor, Mary J Emond, Deborah A Nickerson, Jay Shendure. Nat Rev Genet 2011
10

Exome sequencing makes medical genomics a reality.
Leslie G Biesecker. Nat Genet 2010
103
10

Return of results: not that complicated?
James P Evans, Barbra B Rothschild. Genet Med 2012
48
10

Patient reactions to personalized medicine vignettes: an experimental design.
Morgan Butrick, Debra Roter, Kimberly Kaphingst, Lori H Erby, Carlton Haywood, Mary Catherine Beach, Howard P Levy. Genet Med 2011
16
25

Taxonomizing, sizing, and overcoming the incidentalome.
Isaac S Kohane, Michael Hsing, Sek Won Kong. Genet Med 2012
90
10

The incidentalome: a threat to genomic medicine.
Isaac S Kohane, Daniel R Masys, Russ B Altman. JAMA 2006
213
10

Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.
Flavia M Facio, Stephanie Brooks, Johanna Loewenstein, Susannah Green, Leslie G Biesecker, Barbara B Biesecker. Eur J Hum Genet 2011
96
10


Genetics professionals' perspectives on reporting incidental findings from clinical genome-wide sequencing.
Zoe Lohn, Shelin Adam, Patricia Birch, Anne Townsend, Jan Friedman. Am J Med Genet A 2013
43
10

Views on personalized medicine: do the attitudes of African American and white prescription drug consumers differ?
M De Marco, S Cykert, N Coad, K Doost, J Schaal, B White, D Young, M R Isler, G Corbie-Smith. Public Health Genomics 2010
12
33

Researchers' views on return of incidental genomic research results: qualitative and quantitative findings.
Robert Klitzman, Paul S Appelbaum, Abby Fyer, Josue Martinez, Brigitte Buquez, Julia Wynn, Cameron R Waldman, Jo Phelan, Erik Parens, Wendy K Chung. Genet Med 2013
82
10

Point-counterpoint. Patient autonomy and incidental findings in clinical genomics.
Susan M Wolf, George J Annas, Sherman Elias. Science 2013
158
10

An evaluation of pharmacists' expectations towards pharmacogenomics.
Simon de Denus, Nathalie Letarte, Thierry Hurlimann, Jean-Philippe Lambert, Annie Lavoie, Laura Robb, Nancy L Sheehan, Jacques Turgeon, Barbara Vadnais. Pharmacogenomics 2013
53
10

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
263
10

Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.
Dean A Regier, Stuart J Peacock, Reka Pataky, Kimberly van der Hoek, Gail P Jarvik, Jeffrey Hoch, David Veenstra. CMAJ 2015
49
10

Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases.
Erika Kleiderman, Bartha Maria Knoppers, Conrad V Fernandez, Kym M Boycott, Gail Ouellette, Durhane Wong-Rieger, Shelin Adam, Julie Richer, Denise Avard. J Med Ethics 2014
53
10

"Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing.
Susan Brown Trinidad, Tara B Coffin, Stephanie M Fullerton, James Ralston, Gail P Jarvik, Eric B Larson. Perm J 2015
9
44

Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.
K Lachance, S Korol, E O'Meara, A Ducharme, N Racine, M Liszkowski, J L Rouleau, G B Pelletier, M Carrier, M White,[...]. Pharmacogenomics J 2015
7
57


Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
353
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.